Micardis and Macrobid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micardis and Macrobid. Common interactions include flatulence among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people who take Micardis and Macrobid have. It is created by eHealthMe based on reports of 18 people who take Micardis and Macrobid from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Aug, 18, 2022

18 people who take Micardis and Macrobid together, and have interactions are studied.


What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 25,951 Micardis users for its effectiveness, alternative drugs and more.

What is Macrobid?

Macrobid has active ingredients of nitrofurantoin; nitrofurantoin, macrocrystalline. It is often used in urinary tract infection. eHealthMe is studying from 7,896 Macrobid users for its effectiveness, alternative drugs and more.

Number of Micardis and Macrobid reports submitted per year:

Micardis and Macrobid drug interactions.

Common Micardis and Macrobid drug interactions by gender *:

female:

  1. Flatulence
  2. Flushing
  3. Gamma-glutamyltransferase increased
  4. Gastritis
  5. Hepatitis
  6. Herpes zoster
  7. Hyperbilirubinaemia
  8. Jaundice
  9. Knee arthroplasty
  10. Nervousness

male:

  1. Abdominal distension
  2. Abdominal pain
  3. Dizziness
  4. Drug hypersensitivity
  5. Dyspepsia
  6. Fatigue
  7. Feeling hot
  8. Feeling of body temperature change
  9. Flatulence
  10. Heart rate decreased

Common Micardis and Macrobid drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Altered state of consciousness
  2. Crepitations
  3. Discomfort
  4. Dyspnoea
  5. Irritability
  6. Pneumonia aspiration
  7. Rales
  8. Urinary incontinence
  9. Urinary tract infection pseudomonal
  10. Wheezing

50-59:

  1. Alanine aminotransferase increased
  2. Aspartate aminotransferase increased
  3. Blood alkaline phosphatase increased
  4. Blood lactate dehydrogenase increased
  5. Fatigue
  6. Gamma-glutamyltransferase increased
  7. Hepatitis
  8. Hyperbilirubinaemia
  9. Jaundice

60+:

  1. Nausea
  2. Agitation
  3. Heart rate decreased
  4. Hypotension
  5. Muscle spasms
  6. Nightmare
  7. Orthostatic hypotension
  8. Palpitations
  9. Pharyngeal oedema
  10. Restless legs syndrome

Common conditions people have *:

  1. Pain: 5 people, 27.78%
  2. Immunodeficiency Common Variable: 4 people, 22.22%
  3. Type 2 Diabetes: 4 people, 22.22%
  4. Insomnia (sleeplessness): 3 people, 16.67%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 16.67%
  6. Nausea (feeling of having an urge to vomit): 2 people, 11.11%
  7. Gout (uric acid crystals building up in the body): 2 people, 11.11%
  8. Migraine (headache): 2 people, 11.11%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
  10. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and Macrobid?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Micardis and Macrobid interactions:

Browse all drug interactions of Micardis and Macrobid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Micardis interactions:

Browse all interactions between Micardis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Macrobid interactions:

Browse all interactions between Macrobid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan and nitrofurantoin; nitrofurantoin, macrocrystalline (the active ingredients of Micardis and Macrobid, respectively), and Micardis and Macrobid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Micardis and Macrobid.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: